Literature DB >> 26497986

Sonoclot(®)-based method to detect iron enhanced coagulation.

Vance G Nielsen1, Jon Henderson2.   

Abstract

Thrombelastographic methods have been recently introduced to detect iron mediated hypercoagulability in settings such as sickle cell disease, hemodialysis, mechanical circulatory support, and neuroinflammation. However, these inflammatory situations may have heme oxygenase-derived, coexistent carbon monoxide present, which also enhances coagulation as assessed by the same thrombelastographic variables that are affected by iron. This brief report presents a novel, Sonoclot-based method to detect iron enhanced coagulation that is independent of carbon monoxide influence. Future investigation will be required to assess the sensitivity of this new method to detect iron mediated hypercoagulability in clinical settings compared to results obtained with thrombelastographic techniques.

Entities:  

Keywords:  Carbon monoxide; Hypercoagulability; Iron; Viscoelasticity; Viscosity

Mesh:

Substances:

Year:  2016        PMID: 26497986     DOI: 10.1007/s11239-015-1293-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  9 in total

1.  Sickle cell disease is associated with iron mediated hypercoagulability.

Authors:  Nirmish Shah; Ian J Welsby; Martha A Fielder; Wayne K Jacobsen; Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

2.  Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen.

Authors:  Vance Girard Nielsen; Wendi Kulin; John Samuel LaWall; Felesia Nancy MacFarland; Andrew Chen; Heidi Adelleen Hadley; Adam James DaDeppo; Evangelina Barbara Steinbrenner; Ryan William Matika
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

3.  Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.

Authors:  Ryan W Matika; Vance G Nielsen; Evangelina B Steinbrenner; Amy N Sussman; Machaiah Madhrira
Journal:  ASAIO J       Date:  2014 Nov-Dec       Impact factor: 2.872

4.  Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease.

Authors:  Vance G Nielsen; Etheresia Pretorius; Janette Bester; Wayne K Jacobsen; Patrick K Boyle; Joao P Reinhard
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

5.  Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.

Authors:  Vance G Nielsen; Ejaz S Khan; James K Kirklin; James F George
Journal:  Thromb Res       Date:  2010-04-20       Impact factor: 3.944

6.  Left Ventricular Assist Device-Associated Carbon Monoxide and Iron-Enhanced Hypercoagulation: Impact of Concurrent Disease.

Authors:  Vance G Nielsen; Michael A Sobieski; Mark S Slaughter
Journal:  ASAIO J       Date:  2015 Jul-Aug       Impact factor: 2.872

7.  Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis.

Authors:  Vance G Nielsen; Etheresia Pretorius
Journal:  Blood Coagul Fibrinolysis       Date:  2014-12       Impact factor: 1.276

Review 8.  Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.

Authors:  Michael T Ganter; Christoph K Hofer
Journal:  Anesth Analg       Date:  2008-05       Impact factor: 5.108

9.  Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms.

Authors:  Vance G Nielsen; Etheresia Pretorius
Journal:  Blood Coagul Fibrinolysis       Date:  2014-10       Impact factor: 1.276

  9 in total
  1 in total

1.  The value of Sonoclot detection technology to guide the clinical medication of the perioperative anticoagulation and antiplatelet therapy in patients with acute myocardial infarction undergoing emergent PCI.

Authors:  Wu-Xiao Yang; Chun-Lin Lai; Fu-Heng Chen; Ji-Rong Wang; You-Rui Ji; Dong-Xia Wang
Journal:  Exp Ther Med       Date:  2017-04-13       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.